SOHO 2023 | Insights into the optimal management of CLL: the importance of patient characteristics
Alessandra Ferrajoli, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some insights into the optimal management of chronic lymphocytic leukemia (CLL), highlighting the importance of considering patient-related factors and characteristics. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript (edited for clarity)
So to me, the optimal management for CLL is based on the individual characteristics of the patients. So we really need to take a deep definition of what are their prognostic factors. And then for patients that have favorable prognostic factor, I feel that many of the combinations that I mentioned before are going to be excellent in giving good, long lasting results with finite therapy. However, it is also important to identify the patients that have less favorable features for which we need to do a treatment that is going to be based on quality of response and depth of response...
So to me, the optimal management for CLL is based on the individual characteristics of the patients. So we really need to take a deep definition of what are their prognostic factors. And then for patients that have favorable prognostic factor, I feel that many of the combinations that I mentioned before are going to be excellent in giving good, long lasting results with finite therapy. However, it is also important to identify the patients that have less favorable features for which we need to do a treatment that is going to be based on quality of response and depth of response. And those are patients where we may need to extend treatment longer than the standard two years that has been, you know, one of the longest therapy done for finite duration.
Read more...
